Sarcoma Trials
List of key sarcoma trials
Shitanshu Uppal
GOG 277: Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma
Adjuvant chemotherapy with gemcitabine plus docetaxel followed by doxorubicin does not show superior outcomes compared to observation for high-grade uterine leiomyosarcoma.
GeDDiS Trial: Gemcitabine and docetaxel versus doxorubicin as first-line treatment sarcomas
Doxorubicin remains the standard first-line treatment for most patients with advanced soft-tissue sarcoma, as gemcitabine and docetaxel did not demonstrate superiority in survival outcomes
LMS-04: Doxorubicin alone versus doxorubicin with trabectedin for metastatic or unresectable leiomyosarcoma
The combination of doxorubicin and trabectedin significantly improves progression-free survival compared to doxorubicin alone for the first-line treatment of metastatic or unresectable leiomyosarcoma, with an acceptable safety profile despite increased toxicity.
ABOG Certifying Exam Tips
Publications Update # 49
Negotiations for your next job, detection of ovarian cancer recurrences and the role of trabectedin in ovarian cancer (mito-23 trial). Statistics and sample size calculations for board preparation
Publications Update # 48
Stress Management, Mini-Tutorial - Neuroendocrine Tumors of the Cervix,
Lymphedema after SLND, Confidence Intervals and osteoporosis
GYOEDU Coaching and Mentoring
Mentoring Sessions with Dr. Shitanshu Uppal:
* Over ten years of
GOG 258: Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer